Anatomical Therapeutic Chemical • J05AX15 • sofosbuvir

J Antiinfectives for systemic use

J01 Antibacterials for systemic use

J02 Antimycotics for systemic use

J04 Antimycobacterials

J05 Antivirals for systemic use

J05A Direct acting antivirals

J05AA Thiosemicarbazones

J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors

J05AC Cyclic amines

J05AD Phosphonic acid derivatives

J05AE Protease inhibitors

J05AF Nucleoside and nucleotide reverse transcriptase inhibitors

J05AG Non-nucleoside reverse transcriptase inhibitors

J05AH Neuraminidase inhibitors

J05AJ Integrase inhibitors

J05AP Antivirals for treatment of HIV infections

J05AR Antivirals for treatment of HIV infections, combinations

J05AX Other antivirals

J05AX05 inosine Indicated for: viral infections; immunomodulation

J05AX07 enfuvirtide Indicated for: HIV-1 infection

J05AX09 maraviroc Indicated for: HIV-1 infection

J05AX10 maribavir Indicated for: cytomegalovirus infection

J05AX14 daclatasvir Indicated for: chronic hepatitis C

J05AX15 sofosbuvir Indicated for: chronic hepatitis C

J05AX18 letermovir Indicated for: cytomegalovirus infection

J05AX25 baloxavir marboxil Indicated for: influenza

J05AX27 favipiravir Indicated for: COVID-19

J05AX28 bulevirtide Indicated for: chronic hepatitis D

J05AX29 fostemsavir Indicated for: HIV-1 infection

J05AX31 lenacapavir Indicated for: HIV-1 infection

J06 Immune sera and immunoglobulins

J07 Vaccines